StonvexLoading…
StonvexStonvexStonvexCore line items from CNXC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 (Est.) Expected 2026-06-24 | Q1 2026 2026-02-28 | Annual 2025 2025-11-30 | Q3 2025 2025-08-31 | Q2 2025 2025-05-31 |
|---|---|---|---|---|---|
Revenue | $2.52B | $2.50B | $9.83B | $7.27B | $4.79B |
Operating Income | Not available | $118.56M | $-918.18M | $464.20M | $317.21M |
Net Income | Not available | $21.59M | $-1.28B | $200.46M | $112.35M |
EPS (Diluted) | $2.69 | $0.33 | $-20.36 | $3.01 | $1.68 |
Total Assets | Not available | $10.67B | $10.76B | $12.41B | $12.40B |
Total Liabilities | Not available | $7.89B | $8.02B | $8.07B | $8.12B |
Cash & Equivalents | Not available | $222.70M | $327.35M | $350.26M | $342.76M |
Free Cash Flow OCF − CapEx | Not available | $-137.12M | $572.47M | $291.28M | $131.53M |
Shares Outstanding | Not available | 60.82M | 61.74M | 62.21M | 62.93M |